CRSP logo

CRISPR Therapeutics AG (CRSP) Interest Expense

Annual Interest Expense

N/A

31 December 2023

CRSP Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Expense

N/A

30 September 2024

CRSP Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Interest Expense

N/A

30 September 2024

CRSP TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRSP Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

CRSP Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

CRISPR Therapeutics AG Interest Expense History

DateAnnualQuarterlyTTM
Dec 2016
$8.05 M
-$1000.00(-200.0%)
$8.05 M(-1.2%)
Sept 2016
-
$1000.00(>+9900.0%)
$8.15 M(-0.1%)
June 2016
-
$0.00(-100.0%)
$8.16 M(0.0%)
DateAnnualQuarterlyTTM
Mar 2016
-
$8.05 M(+8031.3%)
$8.16 M(+7523.4%)
Dec 2015
$108.00 K(>+9900.0%)
$99.00 K(+1137.5%)
$107.00 K(+1237.5%)
Sept 2015
-
$8000.00
$8000.00
Dec 2014
$0.00
-
-

FAQ

  • What is the all time high annual interest expense for CRISPR Therapeutics AG?
  • What is the all time high quarterly interest expense for CRISPR Therapeutics AG?
  • What is the all time high TTM interest expense for CRISPR Therapeutics AG?

What is the all time high annual interest expense for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high annual interest expense is $8.05 M

What is the all time high quarterly interest expense for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high quarterly interest expense is $8.05 M

What is the all time high TTM interest expense for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high TTM interest expense is $8.16 M